top of page

RECENT PUBLICATIONS

by DR. SANDRA VERMEULEN
Anchor 1
Accelerated partial breast irradiation: using the CyberKnife as the radiation delivery platform in the treatment of early breast cancer 

Due to a wide- spread increase in mammography screening and improved imag- ing technology, many of these tumors are found early and localized to the breast with nearly 25% presenting as ductal carcinoma in situ (DCIS)...

Stereotactic Radiosurgery for Patients with Vestibular Schwannomas 

The IRSA® (International RadioSurgery Association) Radiosurgery Practice Guideline Initiative aims to improve outcomes for vestibular schwannoma radiosurgery by assisting physicians and clinicians in applying research evidence to clinical decisions while promoting the responsible use of health care resources. 

Stereotactic Radiosurgery for Patients with Metastatic Brain Tumors 

The IRSA® (International RadioSurgery Association) Radiosurgery Practice Guideline Initiative aims to improve outcomes for brain metastases radiosurgery by assisting physicians and clinicians in applying research evidence to clinical decisions while promoting the responsible use of health care resources. 

The stereotactic radiosurgical treatment of common benign brain tumors: pituitary adenomas, vestibular schwannoma and meningiomas 

Several treatment options exist following the diagnosis of common benign intra-cranial tumors including microsurgery, radiation and when appropriate medical management. This article will review the current stereotactic radiosurgical trends in the treatment of pituitary adenomas, vestibular schwannomas and meningiomas. 

CyberKnife stereotactic body radiotherapy and CyberKnife accelerated partial breast irradiation for the treatment of early breast cancer 

Stereotactic body radiotherapy (SBRT) and accelerated partial breast irradiation (APBI) delivered using the CyberKnife radiosurgery system allows coverage of the lumpectomy cavity comparable to brachytherapy without being invasive. Here we review our combined experience treating 46 stage I post- lumpectomy patients with this approach. 

bottom of page